FexSplice: A LightGBM-Based Model for Predicting the Splicing Effect of a Single Nucleotide Variant Affecting the First Nucleotide G of an Exon.

FexSplice web service program LightGBM model first nucleotide of an exon splicing-affecting variants

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
06 09 2023
Historique:
received: 02 08 2023
revised: 30 08 2023
accepted: 04 09 2023
medline: 29 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Single nucleotide variants (SNVs) affecting the first nucleotide G of an exon (Fex-SNVs) identified in various diseases are mostly recognized as missense or nonsense variants. Their effect on pre-mRNA splicing has been seldom analyzed, and no curated database is available. We previously reported that Fex-SNVs affect splicing when the length of the polypyrimidine tract is short or degenerate. However, we cannot readily predict the splicing effects of Fex-SNVs. We here scrutinized the available literature and identified 106 splicing-affecting Fex-SNVs based on experimental evidence. We similarly identified 106 neutral Fex-SNVs in the dbSNP database with a global minor allele frequency (MAF) of more than 0.01 and less than 0.50. We extracted 115 features representing the strength of splicing

Identifiants

pubmed: 37761905
pii: genes14091765
doi: 10.3390/genes14091765
pmc: PMC10531444
pii:
doi:

Substances chimiques

Nucleotides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nucleic Acids Res. 1987 Sep 11;15(17):7155-74
pubmed: 3658675
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Hum Mutat. 2013 Feb;34(2):275-82
pubmed: 23169447
RNA. 2000 Jun;6(6):901-11
pubmed: 10864047
J Virol. 2005 Jul;79(14):9254-69
pubmed: 15994820
Hum Genet. 2017 Jun;136(6):665-677
pubmed: 28349240
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D590-8
pubmed: 16381938
EMBO J. 2021 Nov 15;40(22):e107485
pubmed: 34605568
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Nature. 2020 Jul;583(7818):711-719
pubmed: 32728246
Cell Rep. 2012 Feb 23;1(2):167-78
pubmed: 22574288
Nat Struct Mol Biol. 2009 Sep;16(9):996-1001
pubmed: 19684599
Hum Mutat. 2015 May;36(5):513-23
pubmed: 25684150
Hum Mutat. 2011 Feb;32(2):220-30
pubmed: 21120954
Hum Mutat. 2012 Jan;33(1):81-5
pubmed: 21922594
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Nucleic Acids Res. 2011 May;39(10):4396-404
pubmed: 21288883
Biotechniques. 2006 Aug;41(2):177-81
pubmed: 16925019
Nucleic Acids Res. 2022 Sep 9;50(16):9115-9126
pubmed: 35993808
Nature. 2006 Nov 30;444(7119):580-6
pubmed: 17065982
NAR Genom Bioinform. 2020 May 26;2(2):lqaa038
pubmed: 33543123
Nucleic Acids Res. 1997 Feb 15;25(4):888-96
pubmed: 9016643
Front Genet. 2021 Jul 19;12:701076
pubmed: 34349788
PLoS One. 2014 Feb 21;9(2):e89570
pubmed: 24586880
RNA. 1996 Aug;2(8):735-45
pubmed: 8752084
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Nucleic Acids Res. 2007;35(18):5995-6003
pubmed: 17726045
Nucleic Acids Res. 2021 Jan 8;49(D1):D884-D891
pubmed: 33137190
Wiley Interdiscip Rev RNA. 2018 Jan;9(1):
pubmed: 28949076
PLoS One. 2022 Jun 3;17(6):e0269159
pubmed: 35657932
Nucleic Acids Res. 2008 Apr;36(7):2257-67
pubmed: 18285363
Int J Mol Sci. 2023 Feb 13;24(4):
pubmed: 36835142
Nat Commun. 2020 Sep 21;11(1):4744
pubmed: 32958768
J Hum Genet. 2016 Jul;61(7):633-40
pubmed: 27009626
Mol Cell Biol. 1999 Dec;19(12):8263-71
pubmed: 10567551
Genes (Basel). 2020 Sep 22;11(9):
pubmed: 32971903
Genes Dev. 1991 Apr;5(4):642-55
pubmed: 2010089
Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45
pubmed: 26553804

Auteurs

Atefeh Joudaki (A)

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.

Jun-Ichi Takeda (JI)

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.

Akio Masuda (A)

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.

Rikumo Ode (R)

Department of Materials Science and Engineering, Nagoya University Graduate School of Engineering, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.

Koichi Fujiwara (K)

Department of Materials Science and Engineering, Nagoya University Graduate School of Engineering, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.

Kinji Ohno (K)

Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.

Articles similaires

Humans Recurrence Male Female Middle Aged
Spliceosomes Humans Transcriptome Alternative Splicing RNA Splice Sites
Humans Interleukin-4 Ghana Case-Control Studies Interleukin-4 Receptor alpha Subunit

Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system.

Thabata Martins Ferreira Campuzano, Maria Amelia Carlos Souto Maior Borba, Paula de Mendonça Batista et al.
1.00
Humans Female Uterine Cervical Neoplasms Brazil Middle Aged

Classifications MeSH